Better Bone Health

Pioneering Solutions to Understand, Diagnose,
and Treat Bone Conditions​

Pioneering
Solutions to Understand, Diagnose,
and Treat
Bone Conditions​

Who We Are

Welcome to CompagOs – A leader in the field of human 3D in vitro bone models, paving the way for innovative solutions in bone health. We are on a mission to revolutionize drug development, personalized medicine and regenerative treatments in the domain of bone health.

Discover our services on our Bon3OID™ in vitro models, crafted from human cells. These models serve as a robust foundation for researchers, propelling drug development.​

Future Plans

Utilizing our Bon3OID™ technology, we aim to develop blood-based in vitro diagnostic tools for the early detection of bone diseases such as bone metastasis and osteoporosis, while also advancing regenerative medicine solutions to recreate a patient’s bone tissue in severe cancerous and traumatic conditions.

Who We Are

Welcome to CompagOs – A leader in the field of human 3D in vitro bone models, paving the way for innovative solutions in bone health. We are on a mission to revolutionize drug development, personalized medicine and regenerative treatments in the domain of bone health.​

Discover our services on our Bon3OID™ in vitro models, crafted from human cells. These models serve as a robust foundation for researchers, propelling drug development.​

Future Plans

Utilizing our Bon3OID™ technology, we aim to develop blood-based in vitro diagnostic tools for the early detection of bone diseases such as bone metastasis and osteoporosis, while also advancing regenerative medicine solutions to recreate a patient’s bone tissue in severe cancerous and traumatic conditions.

We use 3D bioprinting to create human mesenchymal stem cell-laden hydrogel scaffolds, either from diseased or healthy donors.

These scaffolds are subjected to cyclic mechanical loading, stimulating cell-mediated mineralization and effectively mimicking human biology. Our bioreactors provide precise stimulation, similar to the mechanical load exerted to cells in bones during everyday activities like walking.

Initially, our organotypic bone models consist of osteoblasts and osteocytes. Depending on specific research and clinical needs, we can introduce other types of cells, including osteoclasts and cancer cells.

How We Make a Difference

Focusing on fields with a high unmet need for better treatments, like osteogenesis imperfecta, osteosarcoma and bone metastases.

Our Supporters

Upcoming Events

Together, at CompagOs, we are creating a healthier future with transformative solutions for bone health. Join us on this exciting journey.

January 27, 2025

Zürich, CH

February 7, 2025

Phoenix AZ, USA

Get In Touch

Interested in our services, collaborating with us, or investing in us?
Contact us or continue exploring our website.